Literature DB >> 22784215

Efficient (18)F-labeling of large 37-amino-acid pHLIP peptide analogues and their biological evaluation.

Pierre Daumar1, Cindy A Wanger-Baumann, NagaVaraKishore Pillarsetty, Laura Fabrizio, Sean D Carlin, Oleg A Andreev, Yana K Reshetnyak, Jason S Lewis.   

Abstract

Solid tumors often develop an acidic microenvironment, which plays a critical role in tumor progression and is associated with increased level of invasion and metastasis. The 37-residue pH (low) insertion peptide (pHLIP) is under study as an imaging platform because of its unique ability to insert into cell membranes at a low extracellular pH (pH(e) < 7). Labeling of peptides with [(18)F]-fluorine is usually performed via prosthetic groups using chemoselective coupling reactions. One of the most successful procedures involves the alkyne-azide copper(I) catalyzed cycloaddition (CuAAC). However, none of the known "click" methods have been applied to peptides as large as pHLIP. We designed a novel prosthetic group and extended the use of the CuAAC "click chemistry" for the simple and efficient (18)F-labeling of large peptides. For the evaluation of this labeling approach, a D-amino acid analogue of WT-pHLIP and an L-amino acid control peptide K-pHLIP, both functionalized at the N-terminus with 6-azidohexanoic acid, were used. The novel 6-[(18)F]fluoro-2-ethynylpyridine prosthetic group, was obtained via nucleophilic substitution on the corresponding bromo-precursor after 10 min at 130 °C with a radiochemical yield of 27.5 ± 6.6% (decay corrected) with high radiochemical purity ≥98%. The subsequent Cu(I)-catalyzed "click" reaction with the azido functionalized pHLIP peptides was quantitative within 5 min at 70 °C in a mixture of water and ethanol using Cu-acetate and sodium L-ascorbate. [(18)F]-D-WT-pHLIP and [(18)F]-L-K-pHLIP were obtained with total radiochemical yields of 5-20% after HPLC purification. The total reaction time was 85 min including formulation. In vitro stability tests revealed high stability of the [(18)F]-D-WT-pHLIP in human and mouse plasma after 120 min, with the parent tracer remaining intact at 65% and 85%, respectively. PET imaging and biodistribution studies in LNCaP and PC-3 xenografted mice with the [(18)F]-D-WT-pHLIP and the negative control [(18)F]-L-K-pHLIP revealed pH-dependent tumor retention. This reliable and efficient protocol promises to be useful for the (18)F-labeling of large peptides such as pHLIP and will accelerate the evaluation of numerous [(18)F]-pHLIP analogues as potential PET tracers.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22784215      PMCID: PMC3529145          DOI: 10.1021/bc3000222

Source DB:  PubMed          Journal:  Bioconjug Chem        ISSN: 1043-1802            Impact factor:   4.774


  30 in total

Review 1.  Positron emission tomography neuroreceptor imaging as a tool in drug discovery, research and development.

Authors:  H D Burns; T G Hamill; W S Eng; B Francis; C Fioravanti; R E Gibson
Journal:  Curr Opin Chem Biol       Date:  1999-08       Impact factor: 8.822

2.  An admonition when measuring the lipophilicity of radiotracers using counting techniques.

Authors:  A A Wilson; L Jin; A Garcia; J N DaSilva; S Houle
Journal:  Appl Radiat Isot       Date:  2001-02       Impact factor: 1.513

Review 3.  Recent progress in fluorine-18 labelled peptide radiopharmaceuticals.

Authors:  S M Okarvi
Journal:  Eur J Nucl Med       Date:  2001-07

4.  Measuring tumor aggressiveness and targeting metastatic lesions with fluorescent pHLIP.

Authors:  Yana K Reshetnyak; Lan Yao; Sida Zheng; Sergey Kuznetsov; Donald M Engelman; Oleg A Andreev
Journal:  Mol Imaging Biol       Date:  2011-12       Impact factor: 3.488

5.  Translocation of molecules into cells by pH-dependent insertion of a transmembrane helix.

Authors:  Yana K Reshetnyak; Oleg A Andreev; Ursula Lehnert; Donald M Engelman
Journal:  Proc Natl Acad Sci U S A       Date:  2006-04-11       Impact factor: 11.205

6.  18F-labeling of peptides by means of an organosilicon-based fluoride acceptor.

Authors:  Ralf Schirrmacher; Gerrit Bradtmöller; Esther Schirrmacher; Oliver Thews; Julia Tillmanns; Thomas Siessmeier; Hans G Buchholz; Peter Bartenstein; Björn Wängler; Christof M Niemeyer; Klaus Jurkschat
Journal:  Angew Chem Int Ed Engl       Date:  2006-09-11       Impact factor: 15.336

Review 7.  Linking oncogenic pathways with therapeutic opportunities.

Authors:  Andrea H Bild; Anil Potti; Joseph R Nevins
Journal:  Nat Rev Cancer       Date:  2006-08-17       Impact factor: 60.716

8.  Spontaneous, pH-dependent membrane insertion of a transbilayer alpha-helix.

Authors:  J F Hunt; P Rath; K J Rothschild; D M Engelman
Journal:  Biochemistry       Date:  1997-12-09       Impact factor: 3.162

9.  All-D amino acid-containing channel-forming antibiotic peptides.

Authors:  D Wade; A Boman; B Wåhlin; C M Drain; D Andreu; H G Boman; R B Merrifield
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

Review 10.  Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment.

Authors:  Rob Cairns; Ioanna Papandreou; Nicholas Denko
Journal:  Mol Cancer Res       Date:  2006-02       Impact factor: 5.852

View more
  35 in total

1.  Tumor-Targeted, Cytoplasmic Delivery of Large, Polar Molecules Using a pH-Low Insertion Peptide.

Authors:  Alexander A Svoronos; Raman Bahal; Mohan C Pereira; Francisco N Barrera; John C Deacon; Marcus Bosenberg; Daniel DiMaio; Peter M Glazer; Donald M Engelman
Journal:  Mol Pharm       Date:  2020-01-13       Impact factor: 4.939

2.  pHLIP®-mediated delivery of PEGylated liposomes to cancer cells.

Authors:  Lan Yao; Jennifer Daniels; Dayanjali Wijesinghe; Oleg A Andreev; Yana K Reshetnyak
Journal:  J Control Release       Date:  2013-02-15       Impact factor: 9.776

3.  Understanding the pharmacological properties of a metabolic PET tracer in prostate cancer.

Authors:  Nerissa Therese Viola-Villegas; Sean D Carlin; Ellen Ackerstaff; Kuntal K Sevak; Vadim Divilov; Inna Serganova; Natalia Kruchevsky; Michael Anderson; Ronald G Blasberg; Oleg A Andreev; Donald M Engelman; Jason A Koutcher; Yana K Reshetnyak; Jason S Lewis
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-01       Impact factor: 11.205

4.  Targeting acidity in diseased tissues: mechanism and applications of the membrane-inserting peptide, pHLIP.

Authors:  John C Deacon; Donald M Engelman; Francisco N Barrera
Journal:  Arch Biochem Biophys       Date:  2014-11-18       Impact factor: 4.013

Review 5.  Applications of pHLIP Technology for Cancer Imaging and Therapy.

Authors:  Linden C Wyatt; Jason S Lewis; Oleg A Andreev; Yana K Reshetnyak; Donald M Engelman
Journal:  Trends Biotechnol       Date:  2017-04-21       Impact factor: 19.536

6.  Family of pH (low) insertion peptides for tumor targeting.

Authors:  Dhammika Weerakkody; Anna Moshnikova; Mak S Thakur; Valentina Moshnikova; Jennifer Daniels; Donald M Engelman; Oleg A Andreev; Yana K Reshetnyak
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

7.  pH (low) insertion peptide (pHLIP) targets ischemic myocardium.

Authors:  Eugene A Sosunov; Evgeny P Anyukhovsky; Alexander A Sosunov; Anna Moshnikova; Dayanjali Wijesinghe; Donald M Engelman; Yana K Reshetnyak; Oleg A Andreev
Journal:  Proc Natl Acad Sci U S A       Date:  2012-12-17       Impact factor: 11.205

8.  Peptide targeting and imaging of damaged lung tissue in influenza-infected mice.

Authors:  Na Li; Lu Yin; Damien Thévenin; Yoshiyuki Yamada; Gino Limmon; Jianzhu Chen; Vincent Tk Chow; Donald M Engelman; Bevin P Engelward
Journal:  Future Microbiol       Date:  2013-02       Impact factor: 3.165

9.  Imaging Tumor Acidity: pH-Low Insertion Peptide Probe for Optoacoustic Tomography.

Authors:  Yana K Reshetnyak
Journal:  Clin Cancer Res       Date:  2015-07-29       Impact factor: 12.531

10.  Caged [(18)F]FDG Glycosylamines for Imaging Acidic Tumor Microenvironments Using Positron Emission Tomography.

Authors:  Robert R Flavell; Charles Truillet; Melanie K Regan; Tanushree Ganguly; Joseph E Blecha; John Kurhanewicz; Henry F VanBrocklin; Kayvan R Keshari; Christopher J Chang; Michael J Evans; David M Wilson
Journal:  Bioconjug Chem       Date:  2015-12-22       Impact factor: 4.774

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.